CME Group Inc. (NASDAQ:CME) Stock Position Raised by Moore Capital Management LP

Moore Capital Management LP grew its stake in CME Group Inc. (NASDAQ:CME) by 3.6% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 46,606 shares of the financial services provider’s stock after buying an additional 1,606 shares during the period. Moore Capital Management LP’s holdings in CME Group were worth $10,823,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CME. New Age Alpha Advisors LLC grew its position in shares of CME Group by 50.0% in the fourth quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 43 shares during the last quarter. Avidian Wealth Enterprises LLC lifted its position in CME Group by 2.6% during the fourth quarter. Avidian Wealth Enterprises LLC now owns 1,769 shares of the financial services provider’s stock worth $411,000 after purchasing an additional 45 shares during the period. TFC Financial Management Inc. boosted its position in shares of CME Group by 8.4% during the 4th quarter. TFC Financial Management Inc. now owns 592 shares of the financial services provider’s stock worth $137,000 after acquiring an additional 46 shares in the last quarter. Waldron Private Wealth LLC increased its stake in shares of CME Group by 2.0% in the 4th quarter. Waldron Private Wealth LLC now owns 2,362 shares of the financial services provider’s stock valued at $549,000 after purchasing an additional 47 shares during the last quarter. Finally, Venturi Wealth Management LLC lifted its holdings in shares of CME Group by 12.1% in the fourth quarter. Venturi Wealth Management LLC now owns 437 shares of the financial services provider’s stock worth $101,000 after acquiring an additional 47 shares during the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on CME shares. Royal Bank of Canada reissued a “sector perform” rating and set a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. UBS Group upped their price objective on CME Group from $290.00 to $305.00 and gave the company a “buy” rating in a research note on Friday, April 25th. Raymond James raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $287.00 target price on the stock in a report on Monday, March 10th. JPMorgan Chase & Co. dropped their price target on shares of CME Group from $223.00 to $211.00 and set an “underweight” rating for the company in a research note on Thursday, April 24th. Finally, Erste Group Bank raised shares of CME Group to a “strong-buy” rating in a research note on Monday, March 17th. Three research analysts have rated the stock with a sell rating, seven have issued a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $256.80.

Insiders Place Their Bets

In other news, insider Derek Sammann sold 4,650 shares of the company’s stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $280.61, for a total transaction of $1,304,836.50. Following the sale, the insider now directly owns 8,336 shares of the company’s stock, valued at $2,339,164.96. This represents a 35.81% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Julie Winkler sold 11,592 shares of the firm’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the completion of the transaction, the insider now directly owns 21,885 shares of the company’s stock, valued at approximately $5,453,085.45. This trade represents a 34.63% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 34,726 shares of company stock valued at $8,975,813. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Performance

NASDAQ:CME opened at $284.35 on Monday. The firm has a market cap of $102.47 billion, a PE ratio of 29.41, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $287.36. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01. The business has a 50 day moving average price of $264.47 and a 200-day moving average price of $245.78.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The business had revenue of $1.64 billion during the quarter, compared to analyst estimates of $1.56 billion. During the same period last year, the business posted $2.50 earnings per share. CME Group’s quarterly revenue was up 10.4% compared to the same quarter last year. Equities research analysts predict that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be issued a dividend of $1.25 per share. The ex-dividend date is Monday, June 9th. This represents a $5.00 annualized dividend and a dividend yield of 1.76%. CME Group’s payout ratio is 50.30%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.